✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

QuidelOrtho Corp

Common Name
QuidelOrtho
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
6,500
Ticker
QDEL
Exchange
Nasdaq
Description
QuidelOrtho Corporation is a leading manufacturer and provider of diagnostic testing solutions that serve the healthcare industry on a global scale. The company focuses on developing innovative diagno...

QuidelOrtho's GHG Emissions Data Preview

In 2023, QuidelOrtho completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, QuidelOrtho has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)20232022
Total Scope 1
22,544a
26,212a
Total Scope 2
Market-Based
29,690a
28,369a
Location-Based
28,009a
26,912a
Total Scope 3
N/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
7.5202a
8.0257a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=QDEL&reporting_period=2023"

Verified Sources Behind QuidelOrtho’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. QuidelOrtho's Sustainability Report 2023

Insights into QuidelOrtho's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of QuidelOrtho amounted to 50,553 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of QuidelOrtho decreased by 4.84%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

QuidelOrtho's Scope 1 Emissions Over Time

2022202307 k14 k21 k28 ktCO2e-14%
  • Total Scope 1
  • Year-over-Year Change

What are QuidelOrtho's Scope 1 emissions?

In 2023, the total Scope 1 emissions of QuidelOrtho were 22,544 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2022), QuidelOrtho's Scope 1 emissions decreased by 13.99%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are QuidelOrtho's Scope 2 emissions?

In 2023, QuidelOrtho reported Scope 2 greenhouse gas (GHG) emissions of 29,690 tCO₂e using the market-based method and 28,009 tCO₂e using the location-based method.a

Has QuidelOrtho reduced its Scope 2 emissions over time?

Compared to the previous year (2022), QuidelOrtho's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that QuidelOrtho's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does QuidelOrtho use for Scope 2 reporting?

In 2023, QuidelOrtho reported its Scope 2 emissions using the market-based method and using the location-based method.a

QuidelOrtho's Scope 2 Emissions Over Time

2022202307.5 k15 k22.5 k30 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into QuidelOrtho’s GHG Emissions Intensity Compared to Industry Peers

In 2023, QuidelOrtho reported Scope 1 greenhouse gas (GHG) emissions of 22,544 tCO₂e and total revenues of USD 2,998 millions. This translates into an emissions intensity of 7.52 tCO₂e per millions USD.a

QuidelOrtho's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)SysmexYear: 2024Scope 1: 13,449 tCO2eRevenue: $M 3,047Scope 1 Intensity: 4.41 tCO2e/$MGetinge publYear: 2025Scope 1: 11,650 tCO2eRevenue: $M 3,802Scope 1 Intensity: 3.06 tCO2e/$MDemantYear: 2025Scope 1: 15,893 tCO2eRevenue: $M 3,616Scope 1 Intensity: 4.40 tCO2e/$MUnited ImagingYear: 2024Scope 1: 3,123 tCO2eRevenue: $M 1,411Scope 1 Intensity: 2.21 tCO2e/$MPHC HoldingsYear: 2023Scope 1: 15,861 tCO2eRevenue: $M 2,676Scope 1 Intensity: 5.93 tCO2e/$MNihon KohdenYear: 2024Scope 1: 4,155 tCO2eRevenue: $M 1,466Scope 1 Intensity: 2.83 tCO2e/$MVarex ImagingYear: 2023Scope 1: 4,856 tCO2eRevenue: $M 893Scope 1 Intensity: 5.44 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MZimmer Biomet HoldingsYear: 2024Scope 1: 10,191 tCO2eRevenue: $M 7,679Scope 1 Intensity: 1.33 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MGE Healthcare TechnologiesYear: 2024Scope 1: 104,974 tCO2eRevenue: $M 19,672Scope 1 Intensity: 5.34 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MStrykerYear: 2023Scope 1: 54,854 tCO2eRevenue: $M 20,498Scope 1 Intensity: 2.68 tCO2e/$MAbbott LaboratoriesYear: 2025Scope 1: 499,000 tCO2eRevenue: $M 44,328Scope 1 Intensity: 11.26 tCO2e/$MAvanos MedicalYear: 2023Scope 1: 1,787 tCO2eRevenue: $M 673Scope 1 Intensity: 2.65 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MBio Rad LaboratoriesYear: 2023Scope 1: 10,563 tCO2eRevenue: $M 2,671Scope 1 Intensity: 3.95 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$MIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MEnovisYear: 2024Scope 1: 2,321 tCO2eRevenue: $M 2,108Scope 1 Intensity: 1.10 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$M

How does QuidelOrtho's GHG emissions intensity compare to its peers?

In 2023, QuidelOrtho reported a Scope 1 emissions intensity of 7.52 tCO₂e per millions USD. Compared to the peer group median of 2.88, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does QuidelOrtho rank on GHG emissions intensity within its industry?

In 2023, QuidelOrtho ranked 22 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places QuidelOrtho among the least efficient performers, with one of the highest emissions intensities in its sector.a

Want Full Access to QuidelOrtho's GHG Emissions Dataset?
Start 30-Day Free Trial